Progyny Inc. Company Profile
NASDAQ: PGNYHealth CareMisc Health and Biotechnology ServicesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Progyny at a glance
Progyny Inc. (NASDAQ: PGNY) is a Misc Health and Biotechnology Services company in the Health Care sector headquartered in New York, NY. Progyny is led by Mr. Peter Anevski CPA and employs about 835 people. The company's shares have traded publicly since 2019.
At a market capitalization of $2.11 billion, it is considered a mid-cap company. Its SEC Central Index Key (CIK) is 0001551306, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Progyny do?
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides access to the medications needed during their treatment and offers care management services, as well as pregnancy and postpartum, menopause and midlife, benefit and leave navigation, and parent and child wellbeing solutions. In addition, it provides assistance service program where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
Business description based on the company's public filings.
Company information
- Legal name
- Progyny Inc.
- Ticker
- NASDAQ: PGNY
- Sector
- Health Care
- Industry
- Misc Health and Biotechnology Services
- CEO
- Mr. Peter Anevski CPA
- Employees
- 835
- Headquarters
- 1359 Broadway, New York, NY, United States
- Phone
- 212 888 3124
- Website
- progyny.com
- IPO year
- 2019
- Market cap
- $2.11B
- SEC CIK
- 0001551306
- Latest annual report
- 10-K · Feb 27, 2026
Companies similar to Progyny
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| PARKPark Dental Partners Inc. | 20.94 | +1.26% | $99.58M | vs PGNY |
| CCELCryo-Cell International Inc. | 3.91 | +0.77% | $31.52M | vs PGNY |
| MGRXMangoceuticals Inc. | 0.4437 | -1.40% | $9.57M | vs PGNY |
| NIVFNewGenIvf Group Limited Class A | 0.106 | +7.40% | $2.89M | vs PGNY |
| SHCSotera Health Company | 17.90 | -1.92% | $5.11B | vs PGNY |
| FMSFresenius Medical Care AG ADR | 20.69 | -7.72% | $11.01B | vs PGNY |
| DVADaVita Inc. | 176.78 | -2.01% | $11.28B | vs PGNY |